Author:
Zheng Zhaoxi,Tang Yabin,Lv Haoyu,Xu Jianrong,Zhao Hengyi,Xie Qiong,Qiu Zhuibai,Chen Hongzhuan,Wang Hao
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference26 articles.
1. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS–amyloid in Alzheimer's disease. Science 330(6012):1774–1774. doi: 10.1126/science.1197623
2. Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S (2007) WITHDRAWN: tacrine for Alzheimer's disease. Cochrane Database Syst Rev 3, CD000202. doi: 10.1002/14651858.CD000202
3. Lilienfeld S (2002) Galantamine-a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev 8(2):159–176
4. Dooley M, Lamb HM (2000) Donepezil: a review of its use in Alzheimer's disease. Drugs Aging 16(3):199–226
5. Onor ML, Trevisiol M, Aguglia E (2007) Rivastigmine in the treatment of Alzheimer's disease: an update. Clin Interv Aging 2(1):17–32
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献